Presentation TCT 2017 Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions? Presenter: Kurt Huber October 30, 2017 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2017 Left Atrial Appendage Up Next Presentation TCT 2017 Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions? Presenter: C. Michael Gibson October 30, 2017 More slides + Presentation TCT 2017 WATCHMAN: Data Synthesis and Ongoing Trials Presenter: William A. Gray October 30, 2017 Presentation TCT 2017 Amulet: Data Synthesis and Ongoing Trials Presenter: Fabian Nietlispach October 30, 2017 We Recommend
Presentation TCT 2017 Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions? Presenter: C. Michael Gibson October 30, 2017
Presentation TCT 2017 WATCHMAN: Data Synthesis and Ongoing Trials Presenter: William A. Gray October 30, 2017
Presentation TCT 2017 Amulet: Data Synthesis and Ongoing Trials Presenter: Fabian Nietlispach October 30, 2017